This is a paid press release. Contact the press release distributor directly with any inquiries.
Lyric Acquires Concert to Advance Healthcare Decision Intelligence and Expand the Lyric42 Platform
Business Wire
Wed, July 15, 2026 at 7:37 PM GMT+5:30
4 min read
Acquisition reinforces Lyric’s commitment to healthcare decision intelligence across the healthcare ecosystem
PHILADELPHIA & NASHVILLE, Tenn., July 15, 2026–(BUSINESS WIRE)–Lyric, a trusted leader in healthcare decision intelligence for payment accuracy, today announced its acquisition of Concert, a precision health payment accuracy leader with proprietary technology for translating machine-readable policies into real-time decisions
The acquisition advances Lyric’s mission to build the most innovative and impactful company in healthcare decision intelligence. By combining Concert’s proprietary capabilities with Lyric42, Lyric’s Healthcare Decision Intelligence Platform, the company extends its ability to serve clients at a time when advanced diagnostics such as genetic testing and the rapid development of new therapies are reshaping healthcare
Health plans face urgent demands to manage rising costs and keep pace with rapidly evolving clinical evidence. To meet these demands, plans require solutions that bring policy, data, and decision-making together in the systems they and their providers already use. The combination of Concert’s policy intelligence with the Lyric42 platform delivers that solution to Lyric’s clients at a critical moment
“Healthcare decision intelligence will define the next decade of this industry, and Lyric is built to lead it,” said Halsey Wise, Lyric CEO. “Healthcare is entering a new era where frontier capabilities are propelling precision diagnostics, personalized therapies, specialty medicines, novel treatment modalities, and rapidly evolving clinical evidence. These themes will all redefine patient care. By combining Concert’s evidence-based, precision medicine capabilities with Lyric’s AI-powered Healthcare Decision Intelligence Platform, we offer our clients critical insights and intelligence. On behalf of our health plan clients, we continue to innovate and activate Lyric42 to create the most unique and powerful decision intelligence platform in the marketplace.”
Concert brings to Lyric a proprietary approach for building machine-readable clinical policy, developed over more than a decade of work in precision health payment accuracy
“Concert was built on the conviction that clinical and administrative policy should be transparent, evidence-based, and computable, delivered into the systems that health plans and providers actually use to make decisions,” said Rob Metcalf, CEO, Concert. “Combining with Lyric allows us to deliver at scale through the Lyric42 platform. Together, we can extend intelligence across the workflows where healthcare decisions are made.”
